M161 M161 Pill - yellow capsule/oblong, 21mm
Pill with imprint M161 M161 is Yellow, Capsule/Oblong and has been identified as Didanosine Delayed Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc.
Didanosine is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M161 M161
Didanosine Delayed Release
- Imprint
- M161 M161
- Strength
- 250 mg
- Color
- Yellow
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-8888 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
carboxymethylcellulose sodium,
silicon dioxide,
diethyl phthalate,
gelatin,
hypromelloses,
methacrylic acid - methyl methacrylate copolymer (1:1),
propylene glycol,
ferric oxide red,
shellac,
trisodium citrate dihydrate,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
potassium hydroxide,
ammonia
Note: Inactive ingredients may vary.
Related images for "M161 M161"
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.